Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer

This study is aimed to investigate the metformin effect on the fertility of women treated with 131 I for thyroid cancer

Trial Details

NCT ID
NCT05468554
Phase
PHASE3
Sponsor
Medical University of Bialystok
Status
RECRUITING
Cancer Type
Papillary Thyroid Cancer
Interventions
  • metformin
  • Radioactive iodine (I-131)
Locations (sample)
  • Bialystok, Poland|53.13333,23.16433
  • Kielce, Świetokrzystie, Poland|50.87033,20.62752

Key Eligibility Criteria

  • Female subjects in reproductive age \>18 \<45 years.
  • Subjects with diagnosed papillary thyroid carcinoma with various pathological stage TNM (I-II).
  • Subjects not treated with 131I
  • Willingness to comply with protocol procedures.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Papillary Thyroid Cancer Trials on Trialify →